Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
May 3, 2004Science

EGFR Mutations in Lung Cancer: Correlation with Clinical Response to Gefitinib Therapy

View Full Paper
Ask AI
Bookmark
Share

Authors

JPJ. Guillermo PaezBroad Institute
Pasi A. Jänne
Pasi A. JänneAstraZeneca (United Kingdom)JLJeffrey C. LeeBroad Institute

Discussion

Loading...

Member takes

Implication

Key Points

Key points are not available for this paper at this time.

Cite This Study

Paez et al. (2004) studied this question.

synapsesocial.com/papers/69d7628aaa68b335b4f3128ehttps://doi.org/10.1126/science.1099314
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Structure of the Epidermal Growth Factor Receptor Kinase Domain Alone and in Complex with a 4-Anilinoquinazoline Inhibitor2002 · 1,585 citations
  2. 2Kinase Mutations and Imatinib Response in Patients With Metastatic Gastrointestinal Stromal Tumor2003 · 2,319 citations
  3. 3Twenty-Two Years of Phase III Trials for Patients With Advanced Non–Small-Cell Lung Cancer: Sobering Results2001 · 355 citations
  4. 4Opportunities and challenges in the development of kinase inhibitor therapy for cancer2003 · 170 citations
  5. 5Use of Chemotherapy plus a Monoclonal Antibody against HER2 for Metastatic Breast Cancer That Overexpresses HER22001 · 11,621 citations